Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 48% by 2022.
  • The company returns high margins, thereby supporting business profitability.
  • The group usually releases upbeat results with huge surprise rates.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 173.23 USD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • With an expected P/E ratio at 47.84 and 41.16 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
DANAHER CORPORATION46.47%159 693
THERMO FISHER SCIENTIFIC45.01%189 801
INTUITIVE SURGICAL, INC.27.09%88 317
SHENZHEN MINDRAY BIO-MEDICA..89.66%62 612
EDWARDS LIFESCIENCES CORPOR..8.62%52 646
ILLUMINA, INC.2.74%49 760
SIEMENS HEALTHINEERS AG-10.32%49 678
BOSTON SCIENTIFIC CORPORATI..-24.48%48 900
KONINKLIJKE PHILIPS N.V.0.72%47 204
AGILENT TECHNOLOGIES, INC.34.30%35 058
RESMED, INC.36.55%30 325
OLYMPUS CORPORATION34.22%28 307
CERNER CORPORATION2.83%23 138
HOLOGIC, INC.35.72%18 212
VARIAN MEDICAL SYSTEMS, INC..22.71%15 920
PERKINELMER, INC.42.72%15 517
More Results
Financials (USD)
Sales 2020 21 959 M - -
Net income 2020 3 386 M - -
Net Debt 2020 16 005 M - -
P/E ratio 2020 47,8x
Yield 2020 0,33%
Capitalization 159 B 159 B -
EV / Sales 2020 7,95x
EV / Sales 2021 6,76x
Nbr of Employees 60 000
Free-Float 74,1%
Upcoming event on DANAHER CORPORATION
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes